Disturbed vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD)
Expanded access could lead to an annual mortality reduction of up to 15.7 deaths per 100,000 individuals, with all states expected to achieve a decrease of 9.6 deaths per 100,000 people
Importantly, these medications carry a boxed warning and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
This test examines 14 metabolic pathways and 150+ genetic insights, including variants in the GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapy
Metoprolol can be an important component of your health management
American Journal of Clinical Nutrition, 115 (3), 608-618